Goedheer, A.J.

tumor cancer patient breast breast cancer tamoxifen level adam -9 therapy disease factor study -11 adam -11 tamoxifen therapy response treatment month progression-free survival disease control nuclei protein analysis control tamoxifen resistance section expression sample receptor assay table survival tissue breast cancer patients group staining carcinoma tamoxifen treatment tumor cells progression-free mmp -2 mmp -9 value first-line stromal result domain follow-up 153 patients stromal cells www.aacrjournals.org metastasi october association remission resistance rna isolation variable estrogen breast carcinomas 106 patients mrna levels housekeeping growth 259 patients correlation diagnosis adjuvant base multivariate model pgr mrna levels pcr master mixture adam -11 protein netherland 0.001 antibody change benefit prognosis univariate product